Daewon Pharmaceutical대원제약
003220 · KOSPI · ₩003220 · 대원제약
₩7,730▲ ₩90 (1.18%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Sep 15, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Aug 28, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 7, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Jun 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 13, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 11, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 11, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Feb 27, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 25, 2026Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)Feb 24, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 20, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 20, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 3, 2026Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 16, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)Nov 24, 2025Open on DART
- Added attachment: Quarterly report (Sep 2025)[첨부추가]분기보고서 (2025.09)Nov 14, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Nov 12, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (DW4421의 제3상 임상시험(비미란성)계획 승인)Oct 28, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (DW4421의 제3상 임상시험(미란성)계획 승인)Oct 15, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 승인)Sep 29, 2025Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 신청)Sep 17, 2025Open on DART
- Results of Rights Offering or Issuance of Equity-Linked Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의발행결과(자율공시)Sep 9, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Sep 9, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Sep 2, 2025Open on DART
- Exchangeable bond issue decision주요사항보고서(교환사채권발행결정)Sep 2, 2025Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Aug 29, 2025Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)Aug 25, 2025Open on DART
- Amended: Capital reduction decision[기재정정]감자결정(종속회사의주요경영사항)Aug 19, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Capital reduction decision감자결정(종속회사의주요경영사항)Aug 12, 2025Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 2, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (코대원플러스정 식품의약품안전처 국내 품목허가 신청)May 30, 2025Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)May 23, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (DW4421 제3상 임상시험계획 승인신청(비미란성) )Apr 30, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (DW4421 제3상 임상시험계획 승인신청(미란성))Apr 30, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 28, 2025Open on DART
- Audit report submitted감사보고서제출Mar 20, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Feb 28, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Feb 27, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Daewon Pharmaceutical / 대원제약 / 003220 / KRX:003220
Source: KRX statistical information